Two spectrophotometric methods described for determination of, Gliclazide and Glibenclamide in bulk and pharmaceutical dosage forms using insitu generated bromine as oxidizing agent and either methylene blue or methyl orange as chromogenic agents. Drugs are treated with known excess of bromine and residual unreacted bromine is determined by treating with fixed amount of either methylene blue or methyl orange then measuring absorbance at 669 nm and 508 nm, respectively. The amount of bromine reacted corresponds to the amount of each drug. Effects of acidity, bromate -bromide volume and reaction time, on the absorption were studied. Calibration curves were linear over ranges of 3-10 μg.ml -1 for Gliclazide, 4-24 μg.ml -1 for Glibenclamide in case of methylene blue and of 2-6 μg.ml -1 for Gliclazide, 4-12μg.ml -1 for Glibenclamide in case of methyl orange. The methods were validated and satisfactory applied for the determination of drugs in both bulk and in tablet form and results were compared statistically with reported methods.
INTRODUCTION
The term diabetes mellitus describes is a metabolic disorder of multiple etiology characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both. (WHO; 1980) The first widely accepted classification of diabetes mellitus was published by the Expert Committee proposed two major classes of diabetes mellitus and named them, (Insulin dependent diabetes mellitus) IDDM or Type 1, and ( non-Insulin dependent diabetes mellitus) NIDDM or Type 2. (WHO; 1997) Gliclazide and Glibenclamide are related to Sulphonylurea drugs group, Gliclazide is a second generation Sulphonylurea drug (Fig.1 ), Gliclazide chemically is 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-tosylurea;1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea.it is official drug (BP, 2013 Ph. Eur. monograph 1524). Several methods have been reported for determination of Gliclazide either alone or in multicomponent formulations. The methods involves different techniques such as spectrophotometric methods (EL-Enany, 2003; EL-Enany, 2004; Revathi et al., 2010; Dhabale and Seervi, 2010; Singh et al., 2011 ) , HPLC methods (Gandhimathi et al.,2003; Kanij et al.,2010; Mansoory and Jain, 2012) . HPTLC method (Patil et al., 2014) , and L.C. method (Vasudevan et al., 2001) .
Glibenclamide is also a second generation Sulphonylurea drug (Fig.1 ). Glibenclamide chemically is 1-{4-[2-(5-Chloro-2-methoxybenzamido) ethyl]benzenesulphonyl}-3-cyclohexylurea, it is official drug (BP, 2013 Ph. Eur. monograph 0718) . Several methods have been reported for determination of Glibenclamide either alone or in multicomponent formulations as UV methods (Patil and Bonde, 2009; Epan et al., 2012; Godse et al.,2012; Parameswararao et al., 2012; Bilal et al., 2013 ) , HPLC methods (Ioannis and Athanasios , 2002; Rajendran, 2007; Venkata, 2011; Angshuman et al., 2012; Jayanthi et al., 2012; Tengli et al., 2013; Narmad et al.,2014; SaiThanuja et al, 2014) , HPTLC methods (Shweta and Sunil, 2010; Sanjay and Mulla , 2104 ) and T.L.C method. ( El-Kousy, 1998 ) .
Redox reactions are employed in determination of inorganic cations and anions as well as organic substances. They have also been used as indicator reaction for kinetic catalytic methods. In redox reactions, the reaction products include the oxidized (or reduced) form of the analyte and the reduced (or oxidized) form of the reagent. Change in the absorbance of one of the reactants or products, induced by the reaction, can be employed in the determination.
An example of redox reactions is the oxidation of the analyte by reagent (bromine) and then excess reagent is determined using other spectrophotometric reaction (such as oxidation of methylene blue or methyl orange by excess bromine followed by determination of residual dye).
This method has been widely employed in determination of pharmaceuticals (as a sensitive and rapid method) such as Cyproheptadin (Basavaiah, 2006) , Amlodipine (Basavaiah and Chandrashekar, 2006) , Salbutamol Sulphate (Somashekar, and Basavaiah, 2007) , Gatifloxacin (Basavaiah K. and Tharpa, 2007a) , Pantoprazole (Basavaiah and Kumar, 2007b) , Simvastatin (Basavaiah, and Tharpa, 2008) , Doxcycline (Ramesh et al., 2010) , levofloxacin HCl, lomefloxacin HCl and sparfloxacin (Elshanawany et al., 2011) , and Cefepime ,Cefoperazone and Ceftriaxone (Elshanawany et al., 2014) . In this study, Gliclazide, Glibenclamide have been determined Spectrophotometrically through indirect redox method depending on oxidation of drugs by insitu generated bromine and evaluation of excess bromine by using either methylene blue or methyl orang.
MATERIAL AND METHODS Apparatus
Schimadzu® (1600) UV-VIS Double Beam Spectrophotometer with matched 1 cm quartz cells
Materials and reagents
All chemicals and reagents were of analytical or pharmaceutical grade. Water was always doubly glass distilled and filtered. 5M HCl (El-Nasr Chemicals,
Egypt) was prepared by dilution of 225ml of concentrated HCl (36%) to 500 ml. Methylene Blue and Methyl Orange 60 µg/ ml (Universal Fine Chemicals, India) stock solutions were prepared by dissolving 60 mg of the dye in 20 ml of absolute methanol then completed to 100 ml with bidistilled water. Working solution was freshly prepared daily by dilution of 10 ml of stock solution to 100 ml with bidistilled water (60µg/ml). Bromate / Bromide stock solution was prepared by dissolving 0.1 gm. of potassium bromate (Winlab, England) and 1.0 gm of potassium bromide (Winlab, England) in 100 ml bidistilled water. Working solution was freshly prepared daily by diluting 2.5 ml of stock solution to 100 ml with bidistilled water (25µg/ml in case of methylene blue), or 1.25 ml of stock solution to 100 ml with bidistilled water (12.5µg/ml in case of methyl orange). Gliclazide purity of 99.85% (EPICO) , Glibenclamide purity of 99.4% (ADCO ) .Standard stock solutions of all drugs were prepared by dissolving 20mg of each pure drug in 100 ml absolute methanol, working solutions of drugs were freshly prepared daily by diluting 10 ml of stock solution to 100 ml with methanol to get final concentration(20µg/ml) Pharmaceutical preparations Diamicron ® tablets labeled to contain 80 mg Gliclazide per tablet batch No.1005019 (Servier, Egypt).,Doanil ® Tablets labeled to contain 5mg Glibenclamide per tablet batch No. 090235\9869 (Sanofi Aventes, Egypt).
General Spectrophotometric procedures and construction of calibration curves using Methylene Blue method
In 10 ml volumetric flasks, add separately 0.15 -0.5 ml (in case of Gliclazide), 0.2 -1.2 ml (in case of Glibenclamide), of woking solution then acidify using 0.4 ml ( in case of Gliclazide) or 0.2ml (in case of , Glibenclamide) of 5 M HCl, add 1 ml of bromate -bromide working solution(25µg/ml) close flasks and stand for 3 minutes, add 1 ml dye M.B working solution(60µg/ml)then stand for another 3 minutes in both drugs. Complete to mark with bidistilled water then measure absorbance at 669 nm against a reagent blank prepared in the same manner except the addition of the drugs. General spectrophotometric procedures and construction of calibration curves using Methyl Orang method In 10 -ml volumetric flasks, add separately 0.1 -0.3 ml (in case of Gliclazide) and 0.2 -0.6ml (in case of Glibenclamide) drug solution then acidify using 0.4 ml of 5 M HCl ,add 1 ml of bromate -bromide working solution(12.5µg/ml) close flasks and stand for 5 minutes, add 1 ml of M.O dye working solution(60 µg/ml) then stand for another 3 minutes( both cases) complete to mark with bidistilled water then measure absorbance at 508 nm against a reagent blank prepared in the same manner except the addition of the drugs..
Preparation and assay of tablet formulations
The total content of twenty tablets of Gliclazide (Diamicron ® ), Glibenclamide (Doanil ® ) , were accurately weighed and grounded well to a fine powder. A portion of the powder equivalent to 20 mg of each drug was dissolved in the least amount of absolute methanol. The resulting solutions were shaken well for 30 min, filtrated through Whatman Grade No. 41 quantitative filter paper and washed with methanol. The filtrate and the washings of drugs were collected in 100 mL volumetric flask, diluted to volume with methanol and the general procedure mentioned above was followed over the calibration range of each compound.
RESULTS and DISCUSSION
The proposed spectrophotometric methods are indirect and are based on the determination of the residual bromine (insitu generated) after allowing the reaction between each drug and a measured amount of bromine to be complete. The excess bromine was determined by reacting with a fixed amount of either methylene blue or methyl orange dye .The methods rely on the bleaching action of bromine on the dyes due to oxidative destruction of these dyes as shown in (Scheme1) (in case of methylene blue) Plater and Arkivoc. (2003) , and the suggested structure of methyl orange before and after oxidation as shown in (Scheme 2). (Basavaiah, and Tharpa, 2008) , Gliclazide and Glibenclamide, when added in increasing amounts to a fixed amount of insitu generated bromine, consume the latter proportionately with a concomitant fall in the concentration of bromine. When a fixed amount of dye is added to the decreasing amounts of bromine, a concomitant increase in the concentration of dye results, Consequently, a proportional increase in the absorbance at the respective λ max is observed with increasing concentration of each drug .The insitu generation of bromine is carried out using a mixture of potassium bromate and potassium bromide in presence of 5 M HCl according to the following equation: 5Br -+ BrO -3 + 6H + 3Br 2 + 3H 2 O Scheme (1) Proposed structures of different forms of methylene blue before and after bromination
CH 3 Br
Methy orang red in acid medium Colourless product Scheme (2) Reaction scheme of methyl orange oxidation by the residual unreacted bromine
Spectral features.
Absorption spectra for determination of Gliclazide and Glibenclamide were studied over range of 200 -800 nm. After oxidation of all drugs and portions of dyes with bromine, residual un-oxidized methylene blue and methyl orange are absorbed at 669 nm and 508 nm respectively ( Fig.1 and Fig.2 ).
Effect of Acidity:
5 M HCl was used throughout experiments and it was found that 0.4 ml ( in case of Gliclazide) and 0.2 ml (in case of Glibenclamide) in M.B method and using 0.4ml (in both Gliclazide and Glibenclamide) In M.O. method.
Effect of bromate -bromide volume:
Bromate -bromide volume was studied by varying the reagent volume Colorless brominated form ISSN 1110-5089 Vol. 24, Issue. 2, pp 97-108 while other factors were held constant. It was found that for both methylene blue and methyl orange methods 1 ml of bromine solution is sufficient for its bleaching action using these stated concentrations (25, 12.5 μg /ml for methylene blue and methyl orange respectively) for all drugs studied.
Effect of time:
Time required for bromination and oxidization the drug before addition of dye and time required to irreversibly oxidize dye after its addition was studied. The bromination reaction was found to be complete in both drugs in 3 minutes with methylene blue and 5 minutes with methyl orange while contact times up to 25 minutes had been examined and no further bromination was detected .A contact time of 3 minutes after addition of dye in both (Gliclazide and Gibenclamide) was necessary for bleaching of dye color by residual bromine and the color of residual dye remain stable (up to 2 hr.) in case of methylene blue and methyl orange respectively.
Method validation
Under the optimum experimental conditions previously described at procedure section the standard calibration graphs for Gliclazide and Glibenclamide were constructed by plotting the absorbance, against concentration using the Microsoft Excel ® spreadsheet program. The parameters, Beer's law limits, regression equations, and correlation coefficient for each drug were presented (Table 1) . Regression analysis reveals a satisfactory correlation for the two methods. Low Sandell's sensitivity values for the two drugs indicate the high specificity and sensitivity of the proposed method. This is also supported by the calculated values of the limit of detection (LOD) and the limit of quantitation (LOQ). The LOD is the smallest concentration of the analyte that is capable of giving a measurable response.
Table (2) Results of the analysis for the proposed methods

Accuracy and precision
The accuracy of an analytical method is the closeness of the test results to the true value. Whereas, precision is an expression for the degree of scattering between a series of measurements obtained from multiple sampling of the same homogenous sample under the prescribed conditions, Precision could be examined in two aspects; firstly, the intra-day precision (repeatability) referring to the use of analytical procedure within a laboratory over a short period of time, at random, by the same operator with the same equipment. The inter-day precision (intermediate precision) involves estimation of variations in analysis when a method is used within a laboratory on different days ( 
Robustness and ruggedness
Robustness of the method was determined by making slight deliberate changes in the operation parameters, such as hydrochloric acid, bromate/bromide mixture ,and dye volumes (±0.2ml), and standing time during the process,. It was observed that there were no marked changes in the color intensity and that is why the developed methods are declared to be robust (Tables 5, 6 
Analysis of pharmaceutical formulations
Both the applicability and validity of the proposed colorimetric method were tested through its application for the determination of Gliclazide, and Glibenclamid in pharmaceuticals manufactured by local Egyptian Companies, at each concentration level, five replicate determinations were performed over a two day design. The recoveries were calculated with reference to the calibration graphs, and satisfactory results were obtained, as presented in (Table7) for M.B and M.O methods respectively. The results obtained were judged and statistically compared with the reported spectrophotometric methods (Singh et al., 2011; Cicy et al., 2012 ) using Student's t-test and the one-way analysis of variance (ANOVA test). Both the t-test values and the variance ratio F-values obtained at the 95 % confidence, did not exceed the theoretical tabulated values. Therefore, there is no significant difference between the proposed and the reported methods indicating that the proposed method is as accurate and precise as the reported methods
Conclusion
The proposed method is simple, sensitive, economic, rapid and practically applicable for the determination of Gliclazid and Glibenclamid in bulk and tablet form without any interference from commonly used pharmaceutical excipients. The proposed method possesses simple cheap equipment, more color stability and wide ranges of analytical determination. There is also, no involvement of any critical and hazardous experimental conditions, expensive reagents or sophisticated instruments (as in HPLC and gas chromatography techniques), which an ordinary analytical laboratory cannot afford .For all of the above, the developed method can be recommended for the routine Q.C. analysis of the drugs, in pure form and in formulations, with speed at low cost without losing the accuracy. (Singh et al.; for Gliclazide (tablet) and (Cicy E. et al. ; 2012) for Glibenclamid (tablet) Tabulated t-value at 95 % confidence limit = 2.13; degree of freedom = 4. Tabulated F-value at 95 % confidence limit = 6.388; degrees of freedom = 4. 
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